Galapagos’ Strategic Shift: Betting On CAR-T And A Fresh Start (Rating Upgrade)By mariocazombo76@gmail.com / February 20, 2025
Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris’ Path January 30, 2025 / DNA, Stephen Ayers / By mariocazombo76@gmail.com
Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain February 2, 2025 / Stephen Ayers, VRTX / By mariocazombo76@gmail.com